![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Swati Spentose Pvt. Ltd. Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Lidocaine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2013-138 - Rev 01
This Chemical Type CEP, issued on April 04, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 727 associated with this CEP further emphasizes